Streetbeat News

Acquisitions Mergers

GRFS

Grifols has completed the sale of a 20% equity stake in SRAAS and has entered into a partnership with Haier Group. This move is part of Grifols' strategy to strengthen its financial position and expand its market presence.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:37 am

BSX

SILK

Silk Road Medical shares are trading higher after the company entered a definitive deal to be acquired by Boston Scientific for $27.50 per share.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:29 am

NVDA

UBER

VOLVY

Waabi, an autonomous trucking startup, has raised $200 million in a Series B funding round with significant investments from Nvidia, Uber, and Volvo. The funds will support Waabi's goal of launching fully driverless trucks by 2025.

Portfolio Pulse from Benzinga Neuro

June 18, 2024 | 11:24 am

FUN

SIX

Cedar Fair and Six Flags Entertainment have announced the senior management team for their combined company, which will operate under the name Six Flags Entertainment Corporation and trade under the ticker symbol 'FUN' on the NYSE. The merger is expected to close on July 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:09 am

FUN

SIX

Cedar Fair and Six Flags Entertainment have notified the NYSE that their previously announced merger of equals is expected to close on July 1, 2024. Additionally, Six Flags has declared a special dividend of $1.53 per share.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:06 am

BSX

SILK

Boston Scientific expects its acquisition of Silk Road Medical to be immaterial to adjusted EPS in 2024 and 2025, but accretive thereafter. Silk Road Medical projects net revenue of $194-198 million in 2024, a 10-12% growth over the prior year. The transaction is expected to close in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:04 am

BSX

SILK

Silk Road Medical has entered a definitive agreement to be acquired by Boston Scientific for $27.50 per share in cash, valuing the deal at approximately $1.26 billion. This price represents a 38% premium to Silk Road Medical's 60-day volume-weighted average share price. Upon completion, Silk Road Medical will become a wholly-owned subsidiary of Boston Scientific.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:01 am

SQNS

Sequans Communications (SQNS) has confirmed that it is in active discussions for a long-term strategic transaction aimed at addressing its debt maturities and strengthening its balance sheet.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:19 am

VRE

Veris Residential has withdrawn its proposed public offering of shares of its common stock and intends to terminate its pending acquisition of 55 Riverwalk Place. No shares will be sold pursuant to the offering.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 10:03 am

HTHIY

JCI

Hitachi is planning to sell its 40% stake in an air-conditioning joint venture with Johnson Controls.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 9:28 am